Kirstin Powel, MS

Scientific Advisory Council Member

Kirstin Powel is owner of and principal consultant at Clearview Consultants LLC. Prior to forming Clearview Consultants, Kirstin served as Vice President of Quality and Regulatory at Talaris Therapeutics until their divestiture and closing. Kirstin previously held positions at Novartis Cell and Gene Therapy Unit where she served most recently as Global Head of Quality Operations. In that role she had quality responsibility for the overall supply chain including the apheresis centers providing apheresis starting material and played a key role in pre-approval inspection preparation and global launch processes for the first FDA-approved CAR-T cell therapy, Kymriah. Ms. Powel was previously employed by Lonza, AG in positions with increasing levels of responsibility in Quality, including in the Global Quality organization with global quality oversight for biologics as well as cell and gene therapy products. Ms. Powel holds a B.A. in biochemistry from Rutgers University and an M.S. in physiology from North Carolina State University.